Article
Thyroid carcinoma-associated genetic mutations also occur in thyroid lymphomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Sept 2012
Aggarwal Nidhi, Swerdlow Steven H, Kelly Lindsey M, Ogilvie Jennifer B, Nikiforova Mariana N, Sathanoori Malini, Nikiforov Yuri E
Abstract excerpt
Molecular testing for mutations activating the mitogen-associated protein kinase signaling pathway is being used to help diagnose thyroid carcinomas. However, the prevalence of these mutations in thyroid lymphomas has not been reported. Therefore, we studied the prevalence of BRAF, NRAS, HRAS, and KRAS mutations in 33 thyroid lymphomas and correlated the mutational status with the clinical, pathological,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.